CINA-AD

Avicenna.AI

CINA-AD is a radiological computer aided triage and notification software indicated for use in the analysis of chest and thoraco-abdominal CT angiographies. The device is intended to assist hospital networks and trained radiologists in workflow triage by flagging and communicating suspected positive findings of chest or thoraco-abdominal CT angiographies for aortic dissection (AD). CINA-AD uses an artificial intelligence algorithm to analyze images and highlight cases with detected AD on a standalone web application in parallel to the ongoing standard of care image interpretation.

Information source: Vendor
Last updated: October 7, 2024

General Information

General
Product name	CINA-AD
Company	Avicenna.AI
Subspeciality	Chest, Abdomen
Modality	CT
Disease targeted	Aortic dissection
Key-features	Aortic dissection triage, aortic dissection detection
Suggested use	Before: adapting worklist order

Technical Specifications

Data characteristics
Population	Adults suspected of aortic dissection
Input	Chest and thoraco-abdominal CT angiographies (CTA)
Input format	DICOM
Output	bounding box annotation, notification
Output format	DICOM SC, GSPS
Technology
Integration	Integration via AI marketplace or distribution platform
Deployment	Locally on dedicated hardware, Locally virtualized (virtual machine, docker)
Trigger for analysis	Automatically, right after the image acquisition
Processing time	10 - 60 seconds

Regulatory

Certification
CE	Certified, Class IIb , MDR
FDA	510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)	CINA CHEST is a radiological computer aided triage and notification software indicated for use in the analysis of Chest and Thoraco-abdominal CT angiography. The device is intended to assist hospital networks and trained radiologists in workflow triage by flagging and communicating suspected positive findings of (1) Chest CT angiography for Pulmonary Embolism (PE) and (2) Chest or Thoraco-abdominal CT angiography for Aortic Dissection (AD). CINA CHEST uses an artificial intelligence algorithm to analyze images and highlight cases with detected PE and AD on a standalone Web application in parallel to the ongoing standard of care image interpretation. The user is presented with notifications for cases with suspected PE or AD findings. Notifications include compressed preview images that are meant for informational purposes only, and are not intended for diagnostic use beyond notification. The device does not alter the original medical image, and it is not intended to be used as a diagnostic device. The results of CINA CHEST are intended to be used in conjunction with other patient information and based on professional judgment to assist with triage/prioritization of medical images. Notified clinicians are ultimately responsible for reviewing full images per the standard of care.

Market

Market presence
On market since	12-2020
Distribution channels	Viz.ai Platform, CARPL.ai, Eureka Clinical AI
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on

Evidence

Evidence
Peer reviewed papers on performance	Diagnostic Performance of a Deep Learning-Powered Application for Aortic Dissection Triage Prioritization and Classification (read)
Non-peer reviewed papers on performance
Other relevant papers